The number of CD83+ DCs was considered a marker of good prognosis, and their density positively correlated with the number of CD4+ or CD8+ T cells [187], thus, suggesting that higher frequencies of mature tumor-infiltrating DCs favor the activation of tumor-specific immunity. This evidence concerns the gene CD83 and neoplasm.